431 related articles for article (PubMed ID: 24832449)
21. Inhibition of ATF6β-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18.
Yamamoto M; Takeda K
Virulence; 2012; 3(1):77-80. PubMed ID: 22286708
[TBL] [Abstract][Full Text] [Related]
22. Comparative virulence of Caribbean, Brazilian and European isolates of Toxoplasma gondii.
Hamilton CM; Black L; Oliveira S; Burrells A; Bartley PM; Melo RPB; Chianini F; Palarea-Albaladejo J; Innes EA; Kelly PJ; Katzer F
Parasit Vectors; 2019 Mar; 12(1):104. PubMed ID: 30871587
[TBL] [Abstract][Full Text] [Related]
23. WITHDRAWN: Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation.
Du J; An R; Chen L; Shen Y; Chen Y; Cheng L; Jiang Z; Zhang A; Yu L; Chu D; Shen Y; Luo Q; Chen H; Wan L; Li M; Xu X; Shen J
J Biol Chem; 2014 May; 289(18):12578-92. PubMed ID: 24648522
[TBL] [Abstract][Full Text] [Related]
24. Translocation of Dense Granule Effectors across the Parasitophorous Vacuole Membrane in
Panas MW; Ferrel A; Naor A; Tenborg E; Lorenzi HA; Boothroyd JC
mSphere; 2019 Jul; 4(4):. PubMed ID: 31366709
[No Abstract] [Full Text] [Related]
25. The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii.
Fentress SJ; Steinfeldt T; Howard JC; Sibley LD
Cell Microbiol; 2012 Dec; 14(12):1921-33. PubMed ID: 22906355
[TBL] [Abstract][Full Text] [Related]
26. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice.
Khan A; Taylor S; Ajioka JW; Rosenthal BM; Sibley LD
PLoS Genet; 2009 Mar; 5(3):e1000404. PubMed ID: 19266027
[TBL] [Abstract][Full Text] [Related]
27.
Hashizaki E; Sasai M; Okuzaki D; Nishi T; Kobayashi T; Iwanaga S; Yamamoto M
mBio; 2023 Feb; 14(1):e0325622. PubMed ID: 36715543
[TBL] [Abstract][Full Text] [Related]
28. Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection.
Wang JL; Bai MJ; Elsheikha HM; Liang QL; Li TT; Cao XZ; Zhu XQ
FASEB J; 2020 Feb; 34(2):3165-3178. PubMed ID: 31908049
[TBL] [Abstract][Full Text] [Related]
29. Have it your way: how polymorphic, injected kinases and pseudokinases enable Toxoplasma to subvert host defenses.
Boothroyd JC
PLoS Pathog; 2013; 9(4):e1003296. PubMed ID: 23633947
[No Abstract] [Full Text] [Related]
30. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases.
Behnke MS; Khan A; Wootton JC; Dubey JP; Tang K; Sibley LD
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9631-6. PubMed ID: 21586633
[TBL] [Abstract][Full Text] [Related]
31. ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.
Yamamoto M; Ma JS; Mueller C; Kamiyama N; Saiga H; Kubo E; Kimura T; Okamoto T; Okuyama M; Kayama H; Nagamune K; Takashima S; Matsuura Y; Soldati-Favre D; Takeda K
J Exp Med; 2011 Jul; 208(7):1533-46. PubMed ID: 21670204
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasma gondii ROP17 inhibits the innate immune response of HEK293T cells to promote its survival.
Li JX; He JJ; Elsheikha HM; Chen D; Zhai BT; Zhu XQ; Yan HK
Parasitol Res; 2019 Mar; 118(3):783-792. PubMed ID: 30675671
[TBL] [Abstract][Full Text] [Related]
33. A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence.
Reese ML; Boothroyd JC
J Biol Chem; 2011 Aug; 286(33):29366-29375. PubMed ID: 21708941
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic secreted kinases are key virulence factors in toxoplasmosis.
Saeij JP; Boyle JP; Coller S; Taylor S; Sibley LD; Brooke-Powell ET; Ajioka JW; Boothroyd JC
Science; 2006 Dec; 314(5806):1780-3. PubMed ID: 17170306
[TBL] [Abstract][Full Text] [Related]
35. Genotyping of polymorphic effectors of Toxoplasma gondii isolates from China.
Cheng W; Wang C; Xu T; Liu F; Pappoe F; Luo Q; Xu Y; Lu F; Shen J
Parasit Vectors; 2017 Nov; 10(1):580. PubMed ID: 29157292
[TBL] [Abstract][Full Text] [Related]
36. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum.
Lei T; Wang H; Liu J; Nan H; Liu Q
PLoS One; 2014; 9(6):e99744. PubMed ID: 24927100
[TBL] [Abstract][Full Text] [Related]
37. ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence.
Singh S; Murillo-León M; Endres NS; Arenas Soto AF; Gómez-Marín JE; Melbert F; Kanneganti TD; Yamamoto M; Campos C; Howard JC; Taylor GA; Steinfeldt T
PLoS Pathog; 2023 Jan; 19(1):e1011003. PubMed ID: 36603017
[TBL] [Abstract][Full Text] [Related]
38. Interactions between the ROP18 kinase and host cell proteins that aid in the parasitism of Toxoplasma gondii.
Cheng L; Chen Y; Chen L; Shen Y; Shen J; An R; Luo Q; Du J
Acta Trop; 2012 Jun; 122(3):255-60. PubMed ID: 22365922
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence.
Fentress SJ; Behnke MS; Dunay IR; Mashayekhi M; Rommereim LM; Fox BA; Bzik DJ; Taylor GA; Turk BE; Lichti CF; Townsend RR; Qiu W; Hui R; Beatty WL; Sibley LD
Cell Host Microbe; 2010 Dec; 8(6):484-95. PubMed ID: 21147463
[TBL] [Abstract][Full Text] [Related]
40. MSCA: a spectral comparison algorithm between time series to identify protein-protein interactions.
Arenas AF; Salcedo GE; Montoya AM; Gomez-Marin JE
BMC Bioinformatics; 2015 May; 16():152. PubMed ID: 25963052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
